NF-kappaB signaling is essential for survival of normal B lymphocytes, and dysregulated NF-kappaB activation contributes to B cell lymphoma and autoimmune disease. Our previous data indicate that the Btk/PKCbeta signaling module plays a crucial, yet highly selective role in B cell activation. PKCbeta is specifically required for B cell receptor (BCR)-mediated NF-kappaB activation. B cells from PKCbeta-deficient mice fail to recruit the lkappaB kinase (IKK) complex into lipid rafts, to activate IKK, to degrade IkappaB, and to upregulate NF-kappaB dependent survival signals. In addition, inhibition of PKCbeta promotes cell death in B lymphomas characterized by exaggerated NF-kappaB activity. Our current studies demonstrate that the MAGUK protein, CARMA1, provides an essential link between PKCbeta and NF-kappaB activation. PKCbeta specifically interacts with, and phosphorylates a highly conserved serine-rich linker within CARMA1. This interaction is predicted to trigger the assembly and activation of theCARMA1/Bcl10/IKK signalosome. In the current proposal we will: 1.) Define the molecular events mediating PKCbeta-dependent CARMA 1 activation and its functional consequences; 2.) Identify the components of the CARMA 1 signalosome; 3.) Characterize key negative regulatory signals mediated by activated PKCbeta and 4.) Determine the developmental consequences of increased dosage and activation of PKCbeta. Together, our previous and new preliminary findings highlight PKCbeta as a key candidate drug target for selected B lineage disorders. Improved understanding of the mechanisms by which PKCbeta regulates NF-kappaB activation; its major protein substrates and downstream transcriptional targets; and the developmental and functional consequences of augmented PKCbeta-dependent signaling will facilitate development of therapeutics specifically targeting these signaling events.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD037091-11
Application #
7435211
Study Section
Immunobiology Study Section (IMB)
Program Officer
Coulombe, James N
Project Start
1999-03-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2011-05-31
Support Year
11
Fiscal Year
2008
Total Cost
$324,065
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Tampella, Giacomo; Kerns, Hannah M; Niu, Deqiang et al. (2015) The Tec Kinase-Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages. J Immunol 195:246-56
Dai, Xuezhi; James, Richard G; Habib, Tania et al. (2013) A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest 123:2024-36
Bermejo, Daniela A; Jackson, Shaun W; Gorosito-Serran, Melisa et al. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR?t and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14:514-22
Moreno-García, Miguel E; Sommer, Karen; Rincon-Arano, Hector et al. (2013) Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-?B activation. Mol Cell Biol 33:1149-63
Allen, Jessica L; Flick, Leah M; Divanovic, Senad et al. (2012) Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous. J Immunol 188:2065-9
Rawlings, David J; Schwartz, Marc A; Jackson, Shaun W et al. (2012) Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol 12:282-94
Meyer-Bahlburg, Almut; Renner, Ellen D; Rylaarsdam, Stacey et al. (2012) Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol 129:559-62, 562.e1-2
Amezcua Vesely, María C; Schwartz, Marc; Bermejo, Daniela A et al. (2012) Fc?RIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol 188:4792-800
Andrews, Sarah F; Dai, Xuezhi; Ryu, Byoung Y et al. (2012) Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells. Eur J Immunol 42:1327-36
Meyer-Bahlburg, Almut; Rawlings, David J (2012) Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) 17:1499-516

Showing the most recent 10 out of 47 publications